Vasopressin V1 receptor-mediated aldosterone production as a result of selective V2 receptor antagonism: A potential explanation for the failure of tolvaptan to reduce cardiovascular outcomes in the EVEREST trial

Bertram Pitt*, Mihai Gheorghiade

*Corresponding author for this work

Research output: Contribution to journalEditorial

8 Scopus citations
Original languageEnglish (US)
Pages (from-to)1261-1263
Number of pages3
JournalEuropean Journal of Heart Failure
Volume13
Issue number12
DOIs
StatePublished - Dec 2011

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this